Multiparametric MRI for prostate cancer diagnosis: current status and future directions

A Stabile, F Giganti, AB Rosenkrantz, SS Taneja… - Nature reviews …, 2020 - nature.com
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

PI-RADS steering committee: the PI-RADS multiparametric MRI and MRI-directed biopsy pathway

AR Padhani, J Barentsz, G Villeirs, AB Rosenkrantz… - Radiology, 2019 - pubs.rsna.org
High-quality evidence shows that MRI in biopsy-naive men can reduce the number of men
who need prostate biopsy and can reduce the number of diagnoses of clinically insignificant …

Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease …

AC Westphalen, CE McCulloch, JM Anaokar, S Arora… - Radiology, 2020 - pubs.rsna.org
Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active
surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) …

[HTML][HTML] Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions

AR Padhani, J Weinreb, AB Rosenkrantz, G Villeirs… - European urology, 2019 - Elsevier
Abstract Context The Prostate Imaging-Reporting and Data System (PI-RADS) v2 analysis
system for multiparametric magnetic resonance imaging (mpMRI) detection of prostate …

CIRSE guidelines on percutaneous needle biopsy (PNB)

A Veltri, I Bargellini, L Giorgi, PAMS Almeida… - Cardiovascular and …, 2017 - Springer
Image-guided percutaneous needle biopsy (PNB) has proven to be a safe and effective
procedure, and it became a common procedure representing an essential step for diagnosis …

The detection of prostate cancer with magnetic resonance imaging-targeted prostate biopsies is superior with the transperineal vs the transrectal approach. A …

F Zattoni, G Marra, V Kasivisvanathan… - The Journal of …, 2022 - auajournals.org
Purpose: Our aim was to evaluate whether transperineal (TP) MRI-targeted prostate biopsy
(TBx) may improve the detection of clinically significant prostate cancer (csPCa), defined as …

[HTML][HTML] Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation

B Israël, M van der Leest, M Sedelaar, AR Padhani… - European urology, 2020 - Elsevier
Background There is large variability among radiologists in their detection of clinically
significant (cs) prostate cancer (PCa) on multiparametric magnetic resonance imaging …

Risk of upgrading from prostate biopsy to radical prostatectomy pathology—does saturation biopsy of index lesion during multiparametric magnetic resonance …

BP Calio, A Sidana, D Sugano, S Gaur… - The Journal of …, 2018 - auajournals.org
Purpose: We sought to determine whether saturation of the index lesion during magnetic
resonance imaging-transrectal ultrasound fusion guided biopsy would decrease the rate of …

Why does magnetic resonance imaging-targeted biopsy miss clinically significant cancer?

C Williams, M Ahdoot, MA Daneshvar… - The Journal of …, 2022 - auajournals.org
Purpose: Multiple studies demonstrate magnetic resonance imaging (MRI)-targeted biopsy
detects more clinically significant cancer than systematic biopsy; however, some clinically …

Validation of PI-RADS version 2 in transition zone lesions for the detection of prostate cancer

JN Thai, HA Narayanan, AK George, MM Siddiqui… - Radiology, 2018 - pubs.rsna.org
Purpose To determine the association between Prostate Imaging Reporting and Data
System (PI-RADS) version 2 scores and prostate cancer (PCa) in a cohort of patients …